A carregar...
Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery
OBJECTIVES: The ongoing COVID-19 pandemic comprises a total of more than 2,350,000 cases and 160,000 deaths. The interest in anti-coronavirus drug development has been limited so far and effective methods to prevent or treat coronavirus infections in humans are still lacking. Urgent action is needed...
Na minha lista:
| Publicado no: | Encephale |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
L'Encéphale, Paris.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188634/ https://ncbi.nlm.nih.gov/pubmed/32387014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.encep.2020.04.010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|